{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:08:06Z","timestamp":1791176886305,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072088","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T17:15:05Z","timestamp":1377796505000},"page":"e72088","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach"],"prefix":"10.1371","volume":"8","author":[{"given":"Simopekka","family":"V\u00e4nsk\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Leino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heini","family":"Salo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Kilpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"J Dillner","year":"2010","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"M Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"N Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"CM Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326 years","volume":"199","author":"CM Wheeler","year":"2009","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"T Malagon","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Palmroth J, Merikukka M, Paavonen J, Apter D, Eriksson T, et al. (2012) Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination. Int J Cancer.","DOI":"10.1002\/ijc.27586"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"JP Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","author":"RV Barnabas","year":"2006","journal-title":"PLoS Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.epidem.2010.02.002","article-title":"HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions","volume":"2","author":"I Baussano","year":"2010","journal-title":"Epidemics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwp466","article-title":"Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus","volume":"171","author":"JA Bogaards","year":"2010","journal-title":"Am J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.vaccine.2009.09.125","article-title":"Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom","volume":"28","author":"YH Choi","year":"2010","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s11538-008-9338-x","article-title":"A multi-type HPV transmission model","volume":"70","author":"EH Elbasha","year":"2008","journal-title":"Bull Math Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e49614","DOI":"10.1371\/journal.pone.0049614","article-title":"Inference of Type-Specific HPV Transmissibility, Progression and Clearance Rates: A Mathematical Modelling Approach","volume":"7","author":"HC Johnson","year":"2012","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","article-title":"Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis","volume":"28","author":"N Van de Velde","year":"2010","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ijc.23670","article-title":"Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland","volume":"123","author":"M Leinonen","year":"2008","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.vaccine.2012.03.065","article-title":"Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model","volume":"30","author":"YH Choi","year":"2012","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.vaccine.2012.01.001","article-title":"Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening","volume":"30","author":"VM Coupe","year":"2012","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/EDE.0b013e31821d107b","article-title":"Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence","volume":"22","author":"JA Bogaards","year":"2011","journal-title":"Epidemiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jnci\/djs395","article-title":"Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis","volume":"104","author":"N Van de Velde","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref21","unstructured":"National Institute for Health and Welfare (THL) (2008\u20132009) School Health Promotion Study in Finland. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.thl.fi\/kouluterveyskysely\/\" xlink:type=\"simple\">http:\/\/www.thl.fi\/kouluterveyskysely\/<\/ext-link>. Accessed 2013 Aug 8."},{"key":"ref22","unstructured":"Kontula O, M\u00e4kinen M (2009) Between Sexual Desire and Reality: The Evolution of Sex in Finland. Family Federation of Finland."},{"key":"ref23","unstructured":"Official Statistics of Finland, Changes in marital status: Newly married women by age and by age of spouse 2008. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/tilastokeskus.fi\/til\/ssaaty\/index_en.html\" xlink:type=\"simple\">http:\/\/tilastokeskus.fi\/til\/ssaaty\/index_en.html<\/ext-link>. Accessed 2013 Aug 8."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"AR Giuliano","year":"2011","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"AC Rodriguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","article-title":"Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity","volume":"70","author":"H Trottier","year":"2010","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","article-title":"High-risk HPV type-specific clearance rates in cervical screening","volume":"96","author":"NW Bulkmans","year":"2007","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00007435-200011000-00011","article-title":"Sexual network structure and sexually transmitted disease prevention: a modeling perspective","volume":"27","author":"M Kretzschmar","year":"2000","journal-title":"Sex Transm Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1099\/vir.0.18995-0","article-title":"Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland","volume":"84","author":"P Laukkanen","year":"2003","journal-title":"J Gen Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1001147","DOI":"10.1371\/journal.pmed.1001147","article-title":"Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models","volume":"8","author":"JA Bogaards","year":"2011","journal-title":"PLoS Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ijc.25675","article-title":"Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33","volume":"128","author":"M Merikukka","year":"2011","journal-title":"Int J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T12:33:40Z","timestamp":1563798820000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072088"}},"subtitle":[],"editor":[{"given":"Joseph T.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072088","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}